Table 4 Relationship between clinicopathological factors and mRNA expression of VEGF-C with Tis, T1tumors
VEGF-C expression | |||||
|---|---|---|---|---|---|
case | mean | ± sd | p-value | ||
age | ≧65 | 8 | -0.11 | ± 0.34 | 0.15 |
< 65 | 13 | 0.12 | ± 0.33 | ||
gender | male | 19 | 0.06 | ± 0.35 | 0.28 |
female | 2 | 0.25 | ± 0.24 | ||
Tfactor | Tis | 6 | -0.02 | ± 0.14 | 0.029 |
T1 | 15 | 0.13 | ± 0.35 | ||
Nfactor | N0 | 12 | -0.15 | ± 0.27 | |
N1 | 9 | 0.27 | ± 0.3 | 0.003 | |
Stage | Stage0 | 6 | -0.23 | ± 0.14 | |
Stage1 | 6 | -0.072 | ± 0.35 | ||
Stage2A | 1 | -0.09 | |||
Stage2B | 8 | 0.31 | ± 0.29 | ||
Stage0,1 vs Stage2A,2B | 0.014 | ||||
Histrogical Type | |||||
well | 4 | 0.45 | ± 0.18 | ||
moderate | 14 | -0.1 | ± 0.29 | ||
poor | 3 | 0.092 | ± 0.36 | ||
well · moderate vs poor | 0.69 | ||||
lymphatic invasion | |||||
positive | 7 | 0.006 | ± 0.39 | ||
negative | 14 | -0.04 | ± 0.34 | 0.77 | |
vein invasion | |||||
positive | 3 | 0.053 | ± 0.51 | ||
negative | 18 | 0.025 | ± 0.33 | > 0.99 | |